Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

Detalles Bibliográficos
Autores principales: Platzbecker, Uwe, Santini, Valeria, Komrokji, Rami S., Zeidan, Amer M., Garcia-Manero, Guillermo, Buckstein, Rena, Miteva, Dimana, Keeperman, Karen, Holot, Natalia, Nadal, Jose Alberto, Lai, Yinzhi, Vodala, Sadanand, Rosettani, Barbara, Giuseppi, Ana Carolina, Yucel, Aylin, Fenaux, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624606/
https://www.ncbi.nlm.nih.gov/pubmed/37752285
http://dx.doi.org/10.1038/s41375-023-02031-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624606/
https://www.ncbi.nlm.nih.gov/pubmed/37752285
http://dx.doi.org/10.1038/s41375-023-02031-7

Ejemplares similares